GL1X · GenesisL1 explorer

Ligand · F7I

F7I · ~{N}-(phenylmethyl)-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide

F7I, ~{N}-(phenylmethyl)-7,10-dioxa-13,17,18,21-tetrazatetracyclo[12.5.2.1^{2,6}.0^{17,20}]docosa-1(20),2(22),3,5,14(21),15,18-heptaene-5-carboxamide (C24 H23 N5 O3, 429.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records…

Component
F7I
Formula
C24 H23 N5 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

F7I in 2 structures; the first of them:

  • 7QUE · The STK17A (DRAK1) Kinase Domain Bound to CKJB68 · F7I A401 · binds LEU67, GLY68, ARG69, GLY70, ALA73, VAL74, VAL75, ALA88 and 13 more
  • 7QUE · The STK17A (DRAK1) kinase domain bound to CKJB68 · F7I A401 · binds LEU67, GLY70, ALA73, VAL75, ALA88, LYS90, LEU138, GLU139 and 7 more

Residues it binds most

ALA 4, LEU 4, GLU 4, GLY 4, VAL 4, ASP 4, LYS 4, TYR 4, ARG 3, ILE 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.